74
Participants
Start Date
February 22, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
January 31, 2028
Specialized Tumor Board Treatment Plan
Specialized Treatment Plan of up to four FDA approved drugs based on participant's screening results will be assigned by PNOC specialized tumor board
Combinations
Specialized Treatment Plan of up to four FDA approved drugs based on participant's screening results will be assigned by PNOC specialized tumor board
RECRUITING
New York University, New York
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
RECRUITING
Children's National Hospital, Washington D.C.
RECRUITING
St. Louis Children's Hospital / Washington University in St. Louis, St Louis
RECRUITING
Children's Hospital of Los Angeles, Los Angeles
RECRUITING
Rady Children's Hospital, San Diego
RECRUITING
University of California, San Francisco, San Francisco
Collaborators (1)
Washington University School of Medicine
OTHER
St. Baldrick's Foundation
OTHER
Ashion Analytics
UNKNOWN
University of Washington
OTHER
Pediatric Neuro-Oncology Consortium
OTHER
University of California, San Francisco
OTHER